These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25350310)

  • 1. [Marked effect of botulinum toxin A for severe toe digital ulcers in a patient with systemic sclerosis].
    Nielsen JB; Hvid L; Olesen AB
    Ugeskr Laeger; 2014 Feb; 176(8A):V08130527. PubMed ID: 25350310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic ulcers on the toes secondary to Raynaud phenomenon in a patient with systemic sclerosis successfully treated with botulinum toxin.
    Garrido-Ríos AA; González-Olivares M; Navarro-Vidal B; Martínez-Morán C; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):503-505. PubMed ID: 29274125
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers.
    Souk JW; Kim HS
    Korean J Intern Med; 2019 Sep; 34(5):1169-1170. PubMed ID: 30099864
    [No Abstract]   [Full Text] [Related]  

  • 5. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis.
    Shenavandeh S; Sepaskhah M; Dehghani S; Nazarinia M
    Clin Rheumatol; 2022 Jan; 41(1):95-104. PubMed ID: 34471968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
    Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
    J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
    Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
    Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injection for refractory Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Shen YH; Lee YH; Leong PY
    Int J Rheum Dis; 2023 Feb; 26(2):187-189. PubMed ID: 36703271
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-healing ischaemic digital ulcer in a systemic sclerosis patient: a challenging clinical case.
    Blaise S; Roustit M; Forli A; Imbert B; Cracowski JL
    Int Wound J; 2017 Dec; 14(6):978-981. PubMed ID: 28303689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon.
    Fregene A; Ditmars D; Siddiqui A
    J Hand Surg Am; 2009 Mar; 34(3):446-52. PubMed ID: 19258141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Raynaud's digital ulcer with interdigital Botulinum toxin A injection.
    Navarro EP; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2016 Jul; 55(7):1216. PubMed ID: 27155203
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective study of the use of botulinum toxin injections in the treatment of Raynaud's syndrome associated with scleroderma.
    Uppal L; Dhaliwal K; Butler PE
    J Hand Surg Eur Vol; 2014 Oct; 39(8):876-80. PubMed ID: 24369360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin-A for the treatment of Raynaud syndrome.
    Smith L; Polsky D; Franks AG
    Arch Dermatol; 2012 Apr; 148(4):426-8. PubMed ID: 22508867
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of vasospastic disorders with botulinum toxin A.
    Van Beek AL; Lim PK; Gear AJL; Pritzker MR
    Plast Reconstr Surg; 2007 Jan; 119(1):217-226. PubMed ID: 17255677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.
    Colglazier CL; Sutej PG; O'Rourke KS
    J Rheumatol; 2005 Dec; 32(12):2440-2. PubMed ID: 16331780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
    Khanna D; Denton CP; Merkel PA; Krieg T; Le Brun FO; Marr A; Papadakis K; Pope J; Matucci-Cerinic M; Furst DE; ;
    JAMA; 2016 May; 315(18):1975-88. PubMed ID: 27163986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A.
    Rodriguez RL; Fernandez HH
    J Clin Neurosci; 2013 Jul; 20(7):1031-2. PubMed ID: 23582954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of hyperbaric oxygen therapy in the treatment of ischemic toe ulcer in a patient presenting systemic sclerosis].
    Poirier E; Wind H; Cordel N
    Ann Dermatol Venereol; 2017 Jan; 144(1):55-59. PubMed ID: 27476378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan for digital ulcers in patients with systemic sclerosis.
    Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
    J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.